Heart failure & cardiomyopathies

Very Long-Term Outcomes of Cardiac Resynchronization Therapy in Patients With Ischemic and Nonischemic Cardiomyopathy

JACC AdvPublished retrospective

Authors' conclusion

Our data suggest that over the very long term (>10 years), patients with NICM had significantly higher survival post-CRT than patients with ischemic cardiomyopathy.

Study context

Population
Patients with ejection fraction (EF) ≤35%, QRS ≥120 ms who underwent CRT-D at the Mayo Clinic between January 2001 and September 2022matched cohort
Participants
610 patients
Exposure
Nonischemic cardiomyopathy (NICM) vs ischemic cardiomyopathy after CRT-D
Outcome
All-cause mortality
Methodological detailssingle-centre (Mayo Clinic), propensity-matched, accelerated failure models with a log-logistic distribution
  • Single-centre (Mayo Clinic)
  • Propensity-matched
  • Accelerated failure models with a log-logistic distribution

Main finding

As reported in the abstract

TR

1.92

P < 0.001

univariate; increased survival with NICM

TR

1.43

P = 0.014

multivariable; increased survival with NICM

Observational data: associations, not effects.

Further findings

Other independent predictors of increased survival post-CRT

Baseline left bundle branch block morphology, decreasing age, higher left ventricular EF, female gender, and absence of the following comorbidities: atrial fibrillation, type 2 diabetes mellitus, and chronic kidney disease 3 or higher

Original publication

Very Long-Term Outcomes of Cardiac Resynchronization Therapy in Patients With Ischemic and Nonischemic Cardiomyopathy. JACC Adv. Published 25 April 2025. doi:10.1016/j.jacadv.2025.101713

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.